Hemostatic Gauze, Chitosan-Based
ID: MW-2405-27Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency Troop Support, is seeking qualified vendors to provide Chitosan-Based Hemostatic Gauze as part of a Combined Synopsis/Solicitation. Vendors must meet specific requirements to be included in the Qualified Supplier List (QSL), including possession of a DAPA number, compliance with FDA regulations, and adherence to technical specifications such as sterility and x-ray detectability. This procurement is crucial for supplying Military Treatment Facilities and ensuring that military personnel have access to safe and effective medical supplies. Interested vendors should contact Dr. Jim Quinn or David Sheaffer for further details, and must submit their qualifications by the established deadlines, with the QSL expected to be finalized by November 1, 2024.

    Point(s) of Contact
    Dr. Jim Quinn Lead MMESO South Clinical Analyst Contractor
    james.e.quinn28.ctr@health.mil
    David Sheaffer MMESO South Team Leader Contractor
    david.v.sheaffer.ctr@health.mil
    Files
    Title
    Posted
    The Defense Health Agency (DHA) Medical Logistics Division is seeking vendor responses for a Sources Sought notification aimed at establishing a Qualified Suppliers Listing (QSL) for Chitosan-Based Hemostatic Gauze. This initiative is designated for products utilized by Military Treatment Facilities (MTFs) and other branches of the U.S. military. Interested vendors must provide a completed QSL Package, including a DAPA or DMM number and documentation related to product origin and compliance with the Trade Agreements Act (TAA). The QSL is expected to be established by November 1, 2024, and vendors will be notified by November 14, 2024, about their eligibility to submit pricing quotes for an Incentive Agreement (IA). Specific product requirements include FDA clearance, sterility, and the addition of x-ray detectable features. Additionally, products must not contain natural rubber latex and must demonstrate compliance with specified packaging and labeling standards. This notice serves as a key governmental procurement effort ensuring that military health needs are met through standardized, safe, and compliant medical supplies.
    The document outlines requirements for vendors seeking qualification for the Qualified Supplier List (QSL) related to the provision of medical/surgical products, specifically Hemostatic Gauze, Chitosan-Based. Key stipulations include the necessity for vendors to possess a DAPA number or show an application in process, and to hold an agreement with the DoD Medical/Surgical Prime Vendors. Vendors must validate their account with the System for Award Management (SAM) and provide specific product details including manufacturer part numbers, packaging information, and compliance with FDA regulations. The technical requirements emphasize that offered products must adhere to specifications, such as being sterile, not containing natural rubber latex, and possessing an x-ray detectable feature. Vendors are required to submit photographic documentation and detailed information supporting their compliance to these criteria. This initiative reflects the federal government's commitment to ensuring that suppliers meet stringent operational standards for medical products, thereby safeguarding public health and meeting military needs.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    Hemostatic Gauze, Kaolin-Based
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking qualified vendors to provide Hemostatic Gauze, Kaolin-Based, as part of a Standardization Action aimed at enhancing procurement efficiency for Military Treatment Facilities (MTFs) across the Army, Navy, Air Force, and Marine Corps. Vendors must be on the Qualified Suppliers List (QSL) MW-2405-26 and are required to submit pricing quotes that are discounted from existing Distribution and Pricing Agreement (DAPA) prices, with selection based on the lowest bid among qualified participants. This initiative is critical for ensuring the availability of essential medical supplies, with an estimated annual demand of approximately $7.36 million. Interested vendors must respond by November 21, 2024, providing necessary company details and pricing information to the designated contacts, Arthur Redmond and David Sheaffer, at their respective email addresses.
    Chlorhexidine Gluconate (CHG) Applicators, Surgical
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors to qualify for a Qualified Suppliers Listing (QSL) for Chlorhexidine Gluconate (CHG) Applicators, Surgical. This initiative aims to standardize the procurement of these medical supplies for Military Treatment Facilities (MTFs) and operational units across the Armed Forces, with an estimated annual sales volume of approximately $908,392. Vendors must meet stringent compliance criteria, including having a DAPA number, an active CAGE Code, and ensuring that products are manufactured in Trade Agreements Act (TAA) compliant countries, while also adhering to FDA regulations. Interested vendors must submit their QSL Package Worksheet and supporting documentation by 5 PM Philadelphia time on November 14, 2024, to Ms. Andrea L. Honesto at andrea.l.honesto.ctr@health.mil, with the QSL expected to be established by December 14, 2024.
    Cloth, Chlorhexidine Gluconate Pre-Op Prep
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cloth, Chlorhexidine Gluconate Pre-Op Prep products, with a presolicitation notice expected to be released on or about February 2, 2025. This initiative aims to solicit information and evaluate products such as single-use, rinse-free cloths pre-saturated with 2% Chlorhexidine Gluconate, which are essential for skin antisepsis prior to surgical procedures. Vendors interested in participating must have a Distribution and Pricing Agreement (DAPA) and ensure their products are manufactured in a Trade Agreements Act (TAA) compliant country, with all relevant details to be made available on the SAM.gov website upon the QSL announcement. For further inquiries, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Specimen Container Peel Pack
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
    Chest Seals, Vented (Vent Mechanism)
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is initiating a procurement opportunity for Vented Chest Seals, specifically targeting vendors on the Qualified Suppliers List (QSL) MW-2404-16. This Standardization Action aims to streamline the supply of these critical medical products to Military Treatment Facilities (MTFs) across all branches of the military, with an estimated annual demand of approximately $2,229,666.02 based on historical usage data. Interested vendors must submit detailed pricing quotes and company information by November 14, 2024, with selection based on the lowest price offered for an initial agreement period of five years. For further inquiries, vendors can contact Arthur Redmond at arthur.b.redmond.ctr@health.mil or David Sheaffer at david.v.sheaffer.ctr@health.mil.
    Cricothyrotomy Kits
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cricothyrotomy Kits, with a presolicitation notice expected to be released on or about December 5, 2024. The procurement aims to identify vendors capable of supplying single-use emergent surgical cricothyrotomy kits that meet specific technical requirements, including a cuffed and flanged airway and various surgical instruments, while ensuring compliance with the Trade Agreements Act (TAA). These kits are critical for emergency medical procedures, emphasizing the importance of having reliable and standardized medical supplies available for military personnel. Interested vendors must ensure they have an active account in the System for Award Management (SAM) and a Distribution and Pricing Agreement (DAPA) in place, with further details to be provided in the forthcoming QSL Announcement. For inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Vaginal Specula Disposable
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
    Non-Reinforced Heat Reflective Shell – Hypothermia Prevention
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-56 Non-Reinforced Heat Reflective Shell, aimed at hypothermia prevention in non-hospital settings. This initiative seeks to identify and evaluate products designed to envelop patients suffering from hypothermia, with specifications including materials such as Bi-axially-oriented polyethylene terephthalate (BoPET) and options for both active and passive heat sources. The QSL will facilitate the procurement of these critical medical supplies, which must comply with Trade Agreements Act (TAA) regulations and be manufactured in compliant countries. Interested vendors should ensure they have an active Distribution and Pricing Agreement (DAPA) and are registered in the System for Award Management (SAM) to participate. For further details, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil, and should monitor the SAM.gov website for the forthcoming QSL Announcement expected around December 12, 2024.
    Skin Staplers
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Skin Staplers, with a presolicitation notice expected to be released on or about February 9, 2025. This initiative aims to solicit information and products for evaluation, focusing on sterile, single patient use skin staplers designed for external skin closure, while excluding reloadable, reprocessed, absorbable, or rotating head staplers. The selected products must comply with the Trade Agreements Act (TAA) and be manufactured in compliant countries, with all vendors required to have a Distribution and Pricing Agreement (DAPA) and an active account in the System for Award Management (SAM). For further details, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or refer to the DLA website for additional information regarding the MSPV program.
    Knee Sleeves, Compression
    Active
    Dept Of Defense
    The US Department of Defense intends to establish a Qualified Suppliers Listing (QSL) for knee compression sleeves, a medical device worn over the knee for support and pain relief. This listing will streamline future procurement processes for these specialized sleeves. The Defense Health Agency seeks to create a comprehensive QSL, which will form the basis of a subsequent Standardization Action and Incentive Agreement. Vendors must have existing contracts with specific medical suppliers and manufacture in Trade Agreements Act-compliant countries to be eligible. This advance notice is a precursor to the official QSL announcement, which will initiate the procurement process and outline participation requirements. Interested parties are advised to prepare, as responses will not be permitted until the official announcement.